Identification of a c-MYB-directed therapeutic for acute myeloid leukemia. (2022)

First Author: Clesham K
Attributed to:  Establishing the mechanism for RUVBL2 essentiality in acute myeloid leukaemia funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41375-022-01554-9

PubMed Identifier: 35368048

Publication URI: http://europepmc.org/abstract/MED/35368048

Type: Journal Article/Review

Volume: 36

Parent Publication: Leukemia

Issue: 6

ISSN: 0887-6924